Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993:(2):16-20.

[The clinical and hemodynamic aspects of using peripheral vasodilators in hypertension in pregnant women]

[Article in Russian]
  • PMID: 8048662
Clinical Trial

[The clinical and hemodynamic aspects of using peripheral vasodilators in hypertension in pregnant women]

[Article in Russian]
O V Osadchaia et al. Akush Ginekol (Mosk). 1993.

Abstract

The clinical efficacy of various vasodilators characterized by different direction of the hemodynamic action (arteriolar, mixed, venous) was assessed in therapy of the slight and medium-severe hypertensive syndrome in 92 pregnant women aged 19-36 at pregnancy terms of 24 to 39 weeks. The drugs were administered as monotherapy. Twenty-two healthy women with the normal gestation process made up the reference group. Echocardiograms have shown before the course of treatment the hyper-, hypo-, and eukinetic changes in the hemodynamics (26, 31, 35 cases, respectively). Venodilators (sustonit-mitte) were found the most effective in the pregnant women with the hyperkinetic type of circulation; in patients with the eu- and hypokinetic type both mixed vasodilators and the arteriolodilators (prazosin, cordafen) were effective. Venodilators are not recommended for patients with the hyperkinetic circulation type because of an undesirable reduction of myocardial contractility.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources